All Stories

  1. Managing the oral side-effects of medications used to treat multiple sclerosis

    Article • Australian Dental Journal, May 2017, Wiley

    Dr Meng-Wong Taing, Dr Pauline J Ford

  2. GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?

    Article • Drug Design Development and Therapy, June 2014, Taylor & Francis

    Dr Meng-Wong Taing